Search Results 1931-1940 of 19097 for Neoplasm
... Neoplastic meningitis. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Pagination Doctor search. PrevPrevious Page · Go to page 11 · Go to page 22 ...
... Neoplastic meningitis. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Rafid Mustafa, M.D.. Neurologist. Rochester, MN. Areas of ...
... Neoplastic meningitis. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Research. With state-of-the-art research and laboratory facilities, Mayo ...
Currently receiving or have received any other investigational agent considered as a treatment for the primary neoplasm ≤ 28 days or within 4 half-lives ...
... Neoplastic meningitis, Brainstem tumor, Leptomeningeal metastases, Diffuse glioma. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Pagination ...
... Neoplastic meningitis, Diffuse glioma, Pilocytic astrocytoma, Plexiform neurofibroma, Diffuse midline glioma. Show more areas of focus for Maciej M. Mrugala ...
(ASM), System Mastocytosis (SM) with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL). Blood-Brain Barrier Disruption (BBBD) for ...
Patients with abnormalities known to be associated with MDS (e.g., del 5q, chr 7 abn) and myeloproliferative neoplasms (MPN, e.g. JAK2 V617F) observed in ...
Cytotoxic Action of Novel Anti-Neoplastic Agents · Collaborators · Contact. Cellular Responses to DNA Damage Induced by Topoisomerase Poisons. The Anticancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!